CLINICAL_TRIALS
trial_result
· 2023-03-08
Clinical Trial Update: Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection [Phase 2]
Summary
A Phase 2 clinical trial update for letermovir in refractory or resistant Cytomegalovirus infection has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amy C. Sherman, MD | Conditions: Cytomegalovirus Infections | Phase 2 | Status: COMPLETED | Results posted: 2023-03-08